Trypanosoma cruzi is the aetiological agent of Chagas disease. Our group has focused on the study of ribosomal RNA and nucleolar structure in this organism. In this work, we address the cellular location of fibrillarin in epimastigotes. As a conserved and unreported feature in trypanosomatids, fibrillarin in T. cruzi is encoded by two genes that differ by approximately 35% in their deduced amino acid sequences (TcFib 1 and TcFib 2). Chimaeric fluorescent versions of TcFib1 and TcFib2 were individually expressed in T. cruzi cells. Both transfected cultures showed cells with a nucleolar fluorescent signal. We have not found any evident distinction between the structure or expression of Tcfibrillarins to propose a functional difference in cells. With the aid of an anti-TcFib 2 antibody, it was found that the endogenous protein relocates outside of the nucleolus in stationary epimastigotes. This was also the case in metacyclic trypomastigotes observed from aged cultures. The significance of this observation is not known, but a deficiency of fibrillarin nucleolar retention correlates with the observed reduction in the abundance of the pre-ribosomal RNAs species at stationary phase, and suggests that the nucleolar location of this protein depends on physiological processes.

We have employed immunocytochemical procedures to localise the nucleolar protein fibrillarin and the enzyme RNA polymerase I in the numerous dense fibrillar bodies (nucleolar precursor bodies) which appear in the nuclei of mammalian early embryos. The aim of this study was to search for relationships between the localisation of these proteins, the changes in the structure of the nucleolar precursor bodies and the resumption of rRNA gene transcription during mouse early embryogenesis. Three human autoimmune sera which recognised fibrillarin and a rabbit antiserum created against RNA Polymerase. I were employed for fluorescence and electron microscopic immunocytochemical assays. A statistical analysis was also applied. Immunocytochemistry revealed that fibrillarin and RNA polymerase I showed the same localisation in the nucleolar precursor bodies. These proteins were immunolocalised only from the late 2-cell stage onward. Fibrillarin was initially detected at the periphery of the nucleolar pricursor bodies and the labelling gradually increased until the morula and blastocyst stages, where normally active nucleoli are found. The pattern of increase of fibrillarin during early embryogenesis shows a parallelism with the rise in rRNA gene transcription occurring during these embryonic stages, and a possible correlation between these two phenomena is suggested. Results demonstrated that nucleolar precursor bodies differ in their biochemical composition from the nucleolus and also from the prenucleolar bodies which appear during mitosis. When anti-fibrillarin antibodies were microinjected into the male pronucleus of mouse embryos to analyse the functions of fibrillarin during early development, they partially blocked the early development of mouse embryos and only 23.8% of injected embryos reach the blastocyst stage.

Eukaryotic nucleoli contain a large family of box C/D small nucleolar ribonucleoprotein complexes (snoRNPs) that are involved in processing and site-specific methylation of pre-rRNA. Several proteins have been reported to be common factors of box C/D snoRNPs in lower and higher eukaryotes; nevertheless none of them has been clearly shown to directly interact with RNA. We previously identified in Xenopus laevis, by means of UV crosslinking in vivo, two proteins associated with box C/D snoRNAs, fibrillarin and p68. Here we show that fibrillarin interacts directly and specifically with the U16 box C/D snoRNA in a X. laevis oocyte nuclear extract and that it does not require p68 for binding. Specific binding is also obtained with a recombinant fibrillarin demonstrating that the protein is able to bind directly and specifically to U16 snoRNA by itself.